Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
FDA officially authorizes Zyn nicotine pouches for sale following health review
Medicare's new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
DentalSense: Your Ultimate Online Guide to Comprehensive Dental Care
Stocks pop on cool inflation, hot bank earnings — plus, new rules on biotech exports to China
